Pharmatimes.com has reported that the new NHS Commissioning Board should see pharmaceutical and medical technology suppliers as partners in innovation.
This was the advice of NHS chief executive Sir David Nicholson, in his initial thoughts on the newly created Board. Sir David has made public his initial ideas before the Board’s proposals have been passed so as to give “a sense of direction” to those involved and external partners who will also be included in the Board’s actions.
The Board will need to develop close links to clinical commissioning groups, the pharmaceutical industry, patient groups and other organisations in order to fully utilise its capabilities. The Board is subject to the passing of the Health and Social Care Bill, and should this bill be successful, then Sir David believes the Board will be fully established by April 2013.
Looking for a job in medical sciences? Start by clicking here, now
